VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Authors: Kastritis, Efstathios ^{1, ⁎}, Beksac, Meral ^{2, 3}, Badelita, Sorina Nicoleta ⁴, Katodritou, Eirini ⁵, Bila, Jelena ⁶, Spanoudakis, Emmanouil ⁷, Seval, Guldane Cengiz ², Cvetkovic, Zorica ⁸, Markovic, Olivera ⁹, Toprak, Selami Koçak ¹⁰, Dalampira, Dimitra ⁵, Coriu, Daniel ¹¹, Bezirgiannidou, Zoi ¹², Pirsic, Mario ¹³, Valkovic, Toni ¹⁴, Ursuleac, Iulia ¹¹, Sretenovic, Aleksandra ⁶, Sevastoudi, Angeliki ⁵, Batinic, Josip ^{15, 16}, Barbu, Sinziana ⁴, Roussou, Maria ¹, Gavriatopoulou, Maria ¹, Terpos, Evangelos ¹, Dimopoulos, Meletios A. ¹

Source: In Clinical Lymphoma, Myeloma and Leukemia February 2025 25(2):e71-e81

Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study Group

Authors: Katodritou, Eirini ^{1, ⁎}, Kastritis, Efstathios ², Dalampira, Dimitra ¹, Fotiou, Despina ², Theodorakakou, Fotini ², Delimpasi, Sosana ³, Spanoudakis, Emmanouil ⁴, Ntanasis-Stathopoulos, Ioannis ², Papadopoulou, Theodosia ¹, Sevastoudi, Aggeliki ¹, Triantafyllou, Theodora ¹, Daiou, Aikaterini ¹, Pouli, Anastasia ⁵, Migkou, Magda ², Gavriatopoulou, Maria ², Verrou, Evgenia ¹, Kyrtsonis, Marie Christine ⁶, Dimopoulos, Meletios-Athanasios ², Terpos, Evangelos ²

Source: In Clinical Lymphoma, Myeloma and Leukemia January 2025

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group

Authors: Fotiou, Despina ¹, Badelita, Sorina Nicoleta ², Katodritou, Eirini ³, Beksac, Meral ⁴, Bila, Jelena ⁵, Spanoudakis, Emmanouil ⁶, Batinić, Josip ⁷, Coriu, Daniel ⁸, Barbu, Sinziana ², Danaila, Catalin ⁹, Dalampira, Dimitra ³, Sevastoudi, Angeliki ³, Seval, Guldane Cengiz ¹⁰, Toprak, Selami Koçak ¹⁰, Sretenovic, Aleksandra ⁵, Markovic, Olivera ¹¹, Valkovic, Toni ^{12, 13}, Cvetkovic, Zorica ¹⁴, Theodorakakou, Fenia ¹, Gavriatopoulou, Maria ¹, Terpos, Evangelos ¹, Dimopoulos, Meletios A. ¹, Kastritis, Efstathios ^{1, ∗}

Source: In Clinical Lymphoma, Myeloma and Leukemia December 2024

Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group

Authors: Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Delimpasi, Sosana, Spanoudakis, Emmanouil, Labropoulou, Vasiliki, Ntanasis‐Stathopoulos, Ioannis, Gkioka, Annita‐Ioanna, Giannakoulas, Nikos, Kanellias, Nikolaos, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michalis, Eyrydiki, Papathanasiou, Maria, Kotsopoulou, Maria, Sioni, Anastasia, Triantafyllou, Theodora, Daiou, Aikaterini, Papadatou, Mavra, Kyrtsonis, Marie‐Christine, Pouli, Anastasia, Kostopoulos, Ioannis, Verrou, Evgenia, Dimopoulos, Meletios‐Athanasios, Terpos, Evangelos

Source: American journal of hematology. 98(5):730-738

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181486398.0x000001&indx=1&recIds=ETOCvdc_100181486398.0x000001

Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications

Authors: Kastritis, Efstathios, Migkou, Magdalini, Dalampira, Dimitra, Gavriatopoulou, Maria, Fotiou, Despina, Roussou, Maria, Kanellias, Nikolaos, Ntanasis‐Stathopoulos, Ioannis, Malandrakis, Panagiotis, Theodorakakou, Foteini, Sevastoudi, Aggeliki, Eleutherakis‐Papaiakovou, Evangelos, Triantafyllou, Theodora, Terpos, Evangelos, Katodritou, Eirini, Dimopoulos, Meletios A.

Source: American journal of hematology. 97(9):1142-1149

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157722635.0x000001&indx=1&recIds=ETOCvdc_100157722635.0x000001

Incidence, characteristics and outcome of therapy‐related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly‐ADPribose polymerase inhibitors: A cancer center experience.

Authors: Verrou, Evgenia, Koutoukoglou, Prodromos, Kontana, Evangelia, Gogolopoulos, Stavros, Sevastoudi, Aggeliki, Daiou, Aikaterini, Dalampira, Dimitra, Triantafyllou, Theodora, Radounislis, Anastasios, Karampatzakis, Nikolaos, Papadopoulou, Theodosia, Giannouli, Eleni, Bouliopoulos, George‐Panteleimon, Yiannaki, Efthalia, Tzimou, Maria, Polychronidou, Genovefa, Papalexandri, Apostolia, Boutis, Anastasios, Katodritou, Eirini

Source: International Journal of Cancer; May2025, Vol. 156 Issue 9, p1686-1691, 6p

Subject Terms: MYELODYSPLASTIC syndromes, ACUTE myeloid leukemia, DISEASE incidence, POLY(ADP-ribose) polymerase, MYELOPROLIFERATIVE neoplasms, CANCER treatment, OVARIAN epithelial cancer

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).

Authors: Kastritis, Efstathios, Katodritou, Eirini, Badelita, Sorina, Bila, Jelena, Seval, Güldane Cengiz, Cvetkovic, Zorica, Coriu, Daniel, Spanoudakis, Emmanouil, Dalampira, Dimitra, Sretenovic, Aleksandra, Sevastoudi, Aggeliki, Bojan, Anca, Mitrovic, Marko, Danaila, Catalin, Gavriatopoulou, Maria, Roussou, Maria, Charalampous, Charalampos, Terpos, Evangelos, Beksac, Meral, Dimopoulos, Meletios A.

Source: Leukemia & Lymphoma; Dec2024, Vol. 65 Issue 13, p2064-2067, 4p

Subject Terms: PROPORTIONAL hazards models, STEM cell transplantation, LACTATE dehydrogenase, PROGNOSTIC tests, PROGNOSTIC models

Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group.

Authors: Katodritou, Eirini, Dalampira, Dimitra, Delimpasi, Sosana, Ntanasis‐Stathopoulos, Ioannis, Karaolidou, Fryni, Gkioka, Annita‐Ioanna, Labropoulou, Vasiliki, Spanoudakis, Emmanouil, Triantafyllou, Theodora, Kotsopoulou, Maria, Michalis, Eyrydiki, Vadikolia, Chrysanthi, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michael, Michael, Daiou, Aikaterini, Pentidou, Aikaterini, Kostopoulos, Ioannis, Palaska, Vasiliki, Gavriatopoulou, Maria

Source: American Journal of Hematology; Oct2024, Vol. 99 Issue 10, p1897-1905, 9p

Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.

Authors: Verrou, Evgenia, Papageorgiou, Sotirios G., Bouzani, Maria, Sevastoudi, Aggeliki, Triantafyllou, Theodora, Daiou, Aikaterini, Dalampira, Dimitra, Arapaki, Maria, Giatra, Chara, Banti, Anastasia, Kyriakidis, Gerasimos, Stoumpos, Dionisios, Karampatzakis, Nikolaos, Papadopoulou, Theodosia, Kotsopoulou, Maria, Pouli, Anastasia, Mandala, Evdokia, Pappa, Vassiliki, Spanoudakis, Emmanouil, Katodritou, Eirini

Source: Hematological Oncology; Sep2024, Vol. 42 Issue 5, p1-7, 7p

Subject Terms: B cell lymphoma, GERMINAL centers, CENTRAL nervous system, OVERALL survival, SURVIVAL rate

Update Analysis of Central Nervous System Multiple Myeloma Prognosis and Survival: A Real-World Multi-Institutional Study of the Greek Myeloma Study Group

Authors: Katodritou, Eirini, Dalampira, Dimitra, Delimpasi, Sosana, Ntanasis-Stathopoulos, Ioannis, Karaolidou, Frini, Gkioka, Annita Ioanna, Labropoulou, Vasiliki, Spanoudakis, Emmanouil, Triantafyllou, Theodora, Kotsopoulou, Maria, Michalis, Eyrydiki, Vadikolia, Chrysanthi, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Michael, Michael, Daiou, Aikaterini, Pentidou, Aikaterini, Kostopoulos, Ioannis V, Palaska, Vasiliki, Gavriatopoulou, Maria, Kyrtsonis, Marie-Christine, Verrou, Evgenia, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos

Source: In Blood 2 November 2023 142 Supplement 1:1981-1981

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Authors: Kastritis, Efstathios, Beksac, Meral, Badelita, Sorina Nicoleta, Katodritou, Eirini, Bila, Jelena, Spanoudakis, Emmanouil, Cengiz Seval, Guldane, Cvetkovic, Zorica, Markovic, Olivera, Toprak, Selami Kocak, Dalampira, Dimitra, Coriu, Daniel, Bezirgiannidou, Zoi, Pirsic, Mario, Valkovic, Toni, Ursuleac, Iulia, Sretenovic, Aleksandra, Sevastoudi, Angeliki, Batinic, Josip, Barbu, Sinziana, Roussou, Maria, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.

Source: In Blood 2 November 2023 142 Supplement 1:4734-4734

P-117 A prognostic score based on age, eGFR (CKD-EPI), performance status and ultra-high-risk disease outperforms R2-ISS for elderly myeloma patients: an analysis of the Greek myeloma study group registry

Authors: Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Sevastoudi, Aggeliki, Theodorakakou, Foteini, Delimpasi, Sosana, Spanoudakis, Emmanouil, Ntanasis-Stathopoulos, Ioannis, Triantafyllou, Theodora, Daiou, Aikaterini, Pouli, Anastasia, Gavriatopoulou, Maria, Verrou, Evgenia, Dimopoulos, Meletios, Terpos, Evangelos

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S99-S100

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.

Authors: Gavriilaki, Eleni¹ (AUTHOR) elenicelli@yahoo.gr, Dalampira, Dimitra² (AUTHOR) dimitradalampira@gmail.com, Theodorakakou, Foteini³ (AUTHOR) foteint@gmail.com, Liacos, Christine-Ivy³ (AUTHOR) liakou@med.uoa.gr, Kanellias, Nikolaos³ (AUTHOR) nick.kanellias@gmail.com, Eleutherakis-Papaiakovou, Evangelos³ (AUTHOR) mdeleutherakis2@gmail.com, Terpos, Evangelos³ (AUTHOR) eterpos@med.uoa.gr, Gavriatopoulou, Maria³ (AUTHOR) mariagabria@gmail.com, Verrou, Evgenia² (AUTHOR) dora_triant@hotmail.com, Triantafyllou, Theodora² (AUTHOR) medsev667@gmail.com, Sevastoudi, Aggeliki² (AUTHOR) eirinikatodritou@gmail.com, Koravou, Evaggelia-Evdoxia¹ (AUTHOR) evakikor@gmail.com, Touloumenidou, Tasoula¹ (AUTHOR) tasoula.touloumenidou@gmail.com, Varelas, Christos¹ (AUTHOR) varelaschris@gmail.com, Papalexandri, Apostolia¹ (AUTHOR) lila.papalexandri@gmail.com, Sakellari, Ioanna¹ (AUTHOR) bmt@gpapanikolaou.gr, Dimopoulos, Meletios A.³ (AUTHOR) mdimop@med.uoa.gr, Kastritis, Efstathios³ (AUTHOR) ekastritis@gmail.com, Katodritou, Eirini² (AUTHOR)

Source: Journal of Clinical Medicine. Jun2022, Vol. 11 Issue 12, p3355. 10p.

Subject Terms: *MULTIPLE myeloma, *PLASMACYTOMA, *PROTEASOME inhibitors

Improved Survival of Patients with Primary Plasma Cell Leukemia with VRD or Daratumumab-Based Quadruplets: A Multicenter Study By the Greek Myeloma Study Group

Authors: Katodritou, Eirini ^*, Kastritis, Efstathios ^*, Dalampira, Dimitra ^*, Delimpasi, Sosana ^*, Spanoudakis, Emmanouil ^*, Labropoulou, Vassiliki ^*, Ntanasis-Stathopoulos, Ioannis ^*, Gkioka, Annita Ioanna ^*, Giannakoulas, Nikolaos ^*, Kanellias, Nikolaos ^*, Sevastoudi, Aggeliki ^*, Michali, Evridiki ^*, Papathanasiou, Maria ^*, Kotsopoulou, Maria ^*, Sioni, Anastasia ^*, Triantafyllou, Theodora ^*, Papadatou, Mavra ^*, Kostopoulos, Ioannis V ^*, Verrou, Evgenia ^*, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos

Source: In Blood 15 November 2022 140 Supplement 1:4386-4387

Self-reported risk of obstructive sleep apnea syndrome, and awareness about it in the community of 4 insular complexes comprising 41 Greek Islands

Authors: Adamou, Anastasia, Giannopoulos, Athanasios-Stefanos, Arvaniti, Christina, Belios, Ioannis, Dalampira, Dimitra, Eleftheriadis, Georgios, Zinoviou, Thomai, Kassas, Petros, Vavougios, George D., Hatzoglou, Chrissi, Gourgoulianis, Konstantinos I., Zarogiannis, Sotirios G.

Source: Sleep Science; March 2022, Vol. 15 Issue: 1, Number 1 Supplement 1 p105-109, 5p

P981: DISEASE CHARACTERISTICS AND TREATMENT OUTCOMES OF MYELOMA PATIENTS <50 YEARS OF AGE: AN ANALYSIS OF THE BALKAN MYELOMA STUDY GROUP.

Authors: Kastritis, Efstathios, Beksac, Meral, Badelita, Sorina, Katodritou, Eirini, Bila, Jelena, Spanoudakis, Emmanouil, Cengiz Seval, Güldane, Cvetkovic, Zorica, Coriu, Daniel, Mitrovic, Marko, Saguna, Carmen, Dalampira, Dimitra, Bojan, Anca, Batinic, Josip, Zver, Samo, Guenova, Margarita, Ivanaj, Arben, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

P956: VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM (R2‐ISS) FOR OVERALL SURVIVAL IN MULTIPLE MYELOMA IN A REAL WORLD COHORT: AN ANALYSIS BY THE BALKAN MYELOMA STUDY GROUP (BMSG)

Authors: Kastritis, Efstathios, Katodritou, Eirini, Badelita, Sorina, Bila, Jelena, Cengiz Seval, Güldane, Cvetkovic, Zorica, Coriu, Daniel, Spanoudakis, Emmanouil, Dalampira, Dimitra, Sretenovic, Aleksandra, Sevastoudi, Aggeliki, Bojan, Anca, Mitrovic, Marko, Danaila, Catalin, Gavriatopoulou, Maria, Roussou, Maria, Dimopoulos, Meletios A., Beksac, Meral, Terpos, Evangelos

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE.

Authors: Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Theodorakakou, Fotini, Fotiou, Despina, Delimpasi, Sosana, Spanoudakis, Emmanouil, Ntanasis‐Stathopoulos, Ioannis, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Triantafyllou, Theodora, Daiou, Aikaterini, Pouli, Anastasia, Migkou, Magdalini, Gavriatopoulou, Maria, Verrou, Evgenia, Christine Kyrtsonis, Marie, Dimopoulos, Meletios A., Terpos, Evangelos

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

P897: EVALUATION OF THE PROGNOSTIC IMPACT OF SECOND LINE ANTI‐MYELOMA TREATMENTS ON POST‐ PROGRESSION OUTCOMES IN THE REAL‐WORLD SETTING: THE GREEK MYELOMA STUDY GROUP EXPERIENCE.

Authors: Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Theodorakakou, Fotini, Delimpasi, Sosana, Spanoudakis, Emmanouil, Ntanasis‐Stathopoulos, Ioannis, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Triantafyllou, Theodora, Daiou, Aikaterini, Labropoulou, Vasiliki, Pouli, Anastasia, Roussou, Maria, Gavriatopoulou, Maria, Verrou, Evgenia, Dimopoulos, Meletios A., Terpos, Evangelos

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

This result is not displayed to guests.
Login for full access.